Anamorelin in patients with advanced non-small cell lung cancer and cachexia: Results from the phase III studies ROMANA 1 and 2

被引：3
|
作者：
Temel, Jennifer S.
Currow, David Christopher
Fearon, Kenneth
Yan, Ying
Friend, John
Abernethy, Amy Pickar
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Flinders Univ S Australia, Adelaide, SA 5001, Australia
[3] Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland
[4] Helsinn Therapeut Inc, Iselin, NJ USA
[5] Duke Univ, Durham, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 29期
关键词：
D O I：
10.1200/jco.2015.33.29_suppl.175
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
175
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Prognostic factors in patients with advanced non-small cell lung cancer: Data from the phase III FLEX study
    Pirker, R.
    Pereira, J. R.
    Szczesna, A.
    von Pawel, J.
    Krzakowski, M.
    Ramlau, R.
    Vynnychenko, I.
    Park, K.
    Eberhardt, W. E. E.
    de Marinis, F.
    Heeger, S.
    Goddemeier, T.
    O'Byrne, K. J.
    Gatzemeier, U.
    LUNG CANCER, 2012, 77 (02) : 376 - 382
  • [32] Nivolumab for advanced non-small cell lung cancer: an evaluation of a phase III study
    Ulmeanu, Ruxandra
    Antohe, Ileana
    Anisie, Ecaterina
    Antoniu, Sabina
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (02) : 165 - 167
  • [33] Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients-Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study
    Takayama, Koichi
    Atagi, Shinji
    Imamura, Fumio
    Tanaka, Hiroshi
    Minato, Koichi
    Harada, Toshiyuki
    Katakami, Nobuyuki
    Yokoyama, Takuma
    Yoshimori, Kozo
    Takiguchi, Yuichi
    Hataji, Osamu
    Takeda, Yuichiro
    Aoe, Keisuke
    Kim, Young Hak
    Yokota, Soichiro
    Tabeta, Hiroshi
    Tomii, Keisuke
    Ohashi, Yasuo
    Eguchi, Kenji
    Watanabe, Koshiro
    SUPPORTIVE CARE IN CANCER, 2016, 24 (08) : 3473 - 3480
  • [34] Plain language summary of a clinical study: anamorelin for treatment of Japanese people with non-small cell lung cancer and cachexia
    Takayama, Koichi
    FUTURE ONCOLOGY, 2024, 20 (24) : 1713 - 1722
  • [35] Impact of tumor genomic alterations on development of cancer cachexia in patients with advanced non-small cell lung cancer
    Fujii, Hiroyuki
    Yoshida, Tatsuya
    Shirasawa, Masayuki
    Fujimoto, Kazushi
    Mizuno, Takaaki
    Sunami, Kuniko
    Koyama, Takafumi
    Motoi, Noriko
    Shinno, Yuki
    Okuma, Yusuke
    Goto, Yasushi
    Horinouchi, Hidehito
    Yamamoto, Noboru
    Ohe, Yuichiro
    ANNALS OF ONCOLOGY, 2023, 34 : S1430 - S1430
  • [36] Phase 2 study of frontline bortezomib in patients with advanced non-small cell lung cancer
    Besse, Benjamin
    Planchard, David
    Veillard, Anne-Sophie
    Taillade, Laurent
    Khayat, David
    Ducourtieux, Muriel
    Pignon, Jean-Pierre
    Lumbroso, Jean
    Lafontaine, Carole
    Mathiot, Claire
    Soria, Jean-Charles
    LUNG CANCER, 2012, 76 (01) : 78 - 83
  • [37] Anamorelin's effect on bone mass: beyond the expected outcomes in non-small cell lung (NSCLC) cancer cachexia
    Lu, M.
    Zabbatino, S. M.
    Garcia, J. M.
    Duus, E. M.
    Friend, J.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S272 - S272
  • [38] Anamorelin and weight gain in patients with advanced nonsmall cell lung cancer (NSCLC) and cachexia: Efficacy and safety in the multinational phase III SCALA program
    Currow, D.
    Chessari, S.
    Bonomi, P.
    Giorgino, R.
    Skipworth, R.
    ANNALS OF ONCOLOGY, 2023, 34 : S1335 - S1335
  • [39] Are the Real World Patients with Advanced Non-Small Cell Lung Cancer Represented in Phase III Immunotherapy Trials?
    Ce Coelho, J.
    Rebelato, T.
    Gelatti, A.
    D'Avila, R.
    Geib, G.
    Rubini Liedke, P.
    Peres Pereira, R.
    Werutsky, G.
    Jobim De Azevedo, S.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1918 - S1918
  • [40] Cachexia Index in Advanced Non-Small-Cell Lung Cancer Patients
    Jafri, Syed Hasan Raza
    Previgliano, Carlos
    Khandelwal, Keerti
    Shi, Runhua
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2015, 9 : 87 - 93
12345